Total Funding
35
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
CloSys develops hemostatic devices used for rapid vascular closure for anti-coagulated patients.
Karol Nowakowski: Founder and CSO- Mary Lach: Chief Financial Officer
About the Company
CloSys Corporation develops hemostatic devices. It offers hemostatic devices, which are used for rapid vascular closure in anticoagulated patients.
